Cargando…

SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer

HIGHLIGHTS: Preliminary results of this work were presented at the 2016 Academic Surgical Congress, Jacksonville (FL), February 2–4 2016 (Original title: Selective Smo-Inhibition Interferes With Cellular Energetic Metabolism In Colorectal Cancer). This study was funded by “Sapienza—University of Rom...

Descripción completa

Detalles Bibliográficos
Autores principales: Magistri, Paolo, Battistelli, Cecilia, Strippoli, Raffaele, Petrucciani, Niccolò, Pellinen, Teijo, Rossi, Lucia, Mangogna, Livia, Aurello, Paolo, D'Angelo, Francesco, Tripodi, Marco, Ramacciato, Giovanni, Nigri, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801594/
https://www.ncbi.nlm.nih.gov/pubmed/29456503
http://dx.doi.org/10.3389/fphar.2017.00956
_version_ 1783298375597162496
author Magistri, Paolo
Battistelli, Cecilia
Strippoli, Raffaele
Petrucciani, Niccolò
Pellinen, Teijo
Rossi, Lucia
Mangogna, Livia
Aurello, Paolo
D'Angelo, Francesco
Tripodi, Marco
Ramacciato, Giovanni
Nigri, Giuseppe
author_facet Magistri, Paolo
Battistelli, Cecilia
Strippoli, Raffaele
Petrucciani, Niccolò
Pellinen, Teijo
Rossi, Lucia
Mangogna, Livia
Aurello, Paolo
D'Angelo, Francesco
Tripodi, Marco
Ramacciato, Giovanni
Nigri, Giuseppe
author_sort Magistri, Paolo
collection PubMed
description HIGHLIGHTS: Preliminary results of this work were presented at the 2016 Academic Surgical Congress, Jacksonville (FL), February 2–4 2016 (Original title: Selective Smo-Inhibition Interferes With Cellular Energetic Metabolism In Colorectal Cancer). This study was funded by “Sapienza—University of Rome” (Funds for young researchers) and “AIRC” (Italian Association for Cancer Research). Hedgehog inhibitor was kindly provided by Genentech, Inc.®. Colon Cancer (CC) is the fourth most frequently diagnosed tumor and the second leading cause of death in the USA. Abnormalities of Hedgehog pathway have been demonstrated in several types of human cancers, however the role of Hedgehog (Hh) in CC remain controversial. In this study, we analyzed the association between increased mRNA expression of GLI1 and GLI2, two Hh target genes, and CC survival and recurrence by gene expression microarray from a cohort of 382 CC patients. We found that patients with increased expression of GLI1 showed a statistically significant reduction in survival. In order to demonstrate a causal role of Hh pathway activation in the pathogenesis of CC, we treated HCT 116, SW480 and SW620 CC cells lines with GDC-0449, a pharmacological inhibitor of Smoothened (SMO). Treatment with GDC-0449 markedly reduced expression of Hh target genes GLI1, PTCH1, HIP1, MUC5AC, thus indicating that this pathway is constitutively active in CC cell lines. Moreover, GDC-0449 partially reduced cell proliferation, which was associated with upregulation of p21 and downregulation of CycD1. Finally, treatment with the same drug reduced migration and three-dimensional invasion, which were associated with downregulation of Snail1, the EMT master gene, and with induction of the epithelial markers Cytokeratin-18 and E-cadherin. These results were confirmed by SMO genetic silencing. Notably, treatment with 5E1, a Sonic Hedgehog-specific mAb, markedly reduced the expression of Hedgehog target genes, as well as inhibited cell proliferation and mediated reversion toward an epithelial phenotype. This suggests the existence of a Hedgehog autocrine signaling loop affecting cell plasticity and fostering cell proliferation and migration/invasion in CC cell lines. These discoveries encourage future investigations to better characterize the role of Hedgehog in cellular plasticity and invasion during the different steps of CC pathogenesis.
format Online
Article
Text
id pubmed-5801594
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58015942018-02-16 SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer Magistri, Paolo Battistelli, Cecilia Strippoli, Raffaele Petrucciani, Niccolò Pellinen, Teijo Rossi, Lucia Mangogna, Livia Aurello, Paolo D'Angelo, Francesco Tripodi, Marco Ramacciato, Giovanni Nigri, Giuseppe Front Pharmacol Pharmacology HIGHLIGHTS: Preliminary results of this work were presented at the 2016 Academic Surgical Congress, Jacksonville (FL), February 2–4 2016 (Original title: Selective Smo-Inhibition Interferes With Cellular Energetic Metabolism In Colorectal Cancer). This study was funded by “Sapienza—University of Rome” (Funds for young researchers) and “AIRC” (Italian Association for Cancer Research). Hedgehog inhibitor was kindly provided by Genentech, Inc.®. Colon Cancer (CC) is the fourth most frequently diagnosed tumor and the second leading cause of death in the USA. Abnormalities of Hedgehog pathway have been demonstrated in several types of human cancers, however the role of Hedgehog (Hh) in CC remain controversial. In this study, we analyzed the association between increased mRNA expression of GLI1 and GLI2, two Hh target genes, and CC survival and recurrence by gene expression microarray from a cohort of 382 CC patients. We found that patients with increased expression of GLI1 showed a statistically significant reduction in survival. In order to demonstrate a causal role of Hh pathway activation in the pathogenesis of CC, we treated HCT 116, SW480 and SW620 CC cells lines with GDC-0449, a pharmacological inhibitor of Smoothened (SMO). Treatment with GDC-0449 markedly reduced expression of Hh target genes GLI1, PTCH1, HIP1, MUC5AC, thus indicating that this pathway is constitutively active in CC cell lines. Moreover, GDC-0449 partially reduced cell proliferation, which was associated with upregulation of p21 and downregulation of CycD1. Finally, treatment with the same drug reduced migration and three-dimensional invasion, which were associated with downregulation of Snail1, the EMT master gene, and with induction of the epithelial markers Cytokeratin-18 and E-cadherin. These results were confirmed by SMO genetic silencing. Notably, treatment with 5E1, a Sonic Hedgehog-specific mAb, markedly reduced the expression of Hedgehog target genes, as well as inhibited cell proliferation and mediated reversion toward an epithelial phenotype. This suggests the existence of a Hedgehog autocrine signaling loop affecting cell plasticity and fostering cell proliferation and migration/invasion in CC cell lines. These discoveries encourage future investigations to better characterize the role of Hedgehog in cellular plasticity and invasion during the different steps of CC pathogenesis. Frontiers Media S.A. 2018-02-02 /pmc/articles/PMC5801594/ /pubmed/29456503 http://dx.doi.org/10.3389/fphar.2017.00956 Text en Copyright © 2018 Magistri, Battistelli, Strippoli, Petrucciani, Pellinen, Rossi, Mangogna, Aurello, D'Angelo, Tripodi, Ramacciato and Nigri. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Magistri, Paolo
Battistelli, Cecilia
Strippoli, Raffaele
Petrucciani, Niccolò
Pellinen, Teijo
Rossi, Lucia
Mangogna, Livia
Aurello, Paolo
D'Angelo, Francesco
Tripodi, Marco
Ramacciato, Giovanni
Nigri, Giuseppe
SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
title SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
title_full SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
title_fullStr SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
title_full_unstemmed SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
title_short SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
title_sort smo inhibition modulates cellular plasticity and invasiveness in colorectal cancer
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801594/
https://www.ncbi.nlm.nih.gov/pubmed/29456503
http://dx.doi.org/10.3389/fphar.2017.00956
work_keys_str_mv AT magistripaolo smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT battistellicecilia smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT strippoliraffaele smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT petruccianiniccolo smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT pellinenteijo smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT rossilucia smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT mangognalivia smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT aurellopaolo smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT dangelofrancesco smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT tripodimarco smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT ramacciatogiovanni smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer
AT nigrigiuseppe smoinhibitionmodulatescellularplasticityandinvasivenessincolorectalcancer